Selleck Chemicals - Model A2665 -Anrukinzumab (Anti-IL-13)

Anrukinzumab (Anti-IL-13) is a humanized monoclonal antibody targeting IL-13. It reduces lung inflammation and can be used in studies of ulcerative colitis (UC) as well as asthma. MW :150 KD.